Safety and Efficacy of Lenvatinib Plus Nivolumab in Unresectable Hepatocellular Carcinoma: A Retrospective Study in China. (2022)

Record Type:
Journal Article
Title:
Safety and Efficacy of Lenvatinib Plus Nivolumab in Unresectable Hepatocellular Carcinoma: A Retrospective Study in China. (2022)
Main Title:
Safety and Efficacy of Lenvatinib Plus Nivolumab in Unresectable Hepatocellular Carcinoma: A Retrospective Study in China
Authors:
Huang, X.
Huang, Z.
Wang, C.
Yin, X.
Xu, L.
Ma, T.
Ran, Y.
Bi, X.
Che, X.
Abstract:
Is Part Of:
HPB. Volume 24(2022)Supplement 1
Journal:
HPB
Issue:
Volume 24(2022)Supplement 1
Issue Display:
Volume 24, Issue 1 (2022)
Year:
2022
Volume:
24
Issue:
1
Issue Sort Value:
2022-0024-0001-0000
Page Start:
S124
Page End:
S125
Publication Date:
2022
Subjects:
Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005
Journal URLs:
https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1016/j.hpb.2022.05.240 ↗
Languages:
English
ISSNs:
1365-182X
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
24089.xml